Literature DB >> 22998187

The SCF ubiquitin ligases involved in hematopoietic lineage.

Kyoko Kitagawa1, Masatoshi Kitagawa.   

Abstract

The ubiquitin-proteasome system is involved in various cellular functions by regulating protein degradation. It has been shown previously that the SCF-type ubiquitin (E3) ligases are involved in cell cycle control. Here we review E3 ligases playing the crucial roles in the determination of cell fate during hematopoiesis. SCFSkp2 controls the degradation of CDK inhibitors, such as p21, p27 and p57, to regulate hematopoietic stem cell lineage. SCFFbw7 targets several important proteins involved in hematopoiesis such as c-Myc, Notch and c-Myb. By controlling the precise levels of these proteins, E3 ligases are required for accurately determining hematopoietic lineage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22998187     DOI: 10.2174/138945012803529974

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  3 in total

1.  Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.

Authors:  Tomomi Nakajima; Kyoko Kitagawa; Tatsuya Ohhata; Satoshi Sakai; Chiharu Uchida; Kiyoshi Shibata; Naoko Minegishi; Kanae Yumimoto; Keiichi I Nakayama; Kazuma Masumoto; Fuminori Katou; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

2.  Fbxw11 impairs the repopulation capacity of hematopoietic stem/progenitor cells.

Authors:  Lina Wang; Yongjun Piao; Dongyue Zhang; Wenli Feng; Chenchen Wang; Xiaoxi Cui; Qian Ren; Xiaofan Zhu; Guoguang Zheng
Journal:  Stem Cell Res Ther       Date:  2022-06-11       Impact factor: 8.079

3.  Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development.

Authors:  Kyoko Kitagawa; Kiyoshi Shibata; Akinobu Matsumoto; Masaki Matsumoto; Tatsuya Ohhata; Keiichi I Nakayama; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.